Insiders / ARCH Venture Fund XIII, L.P. / Activity

Activity — ARCH Venture Fund XIII, L.P.

1 move.

InsidersInstitutions
DateActionCompanyValueShares ΔPosition afterImpact
Mar 6, 2026BuyLYEL
Lyell Immunopharma, Inc.
Common Stock
$12.50M+488K
+52.01%
1,426,528
5.82% of shares
high
← PrevPage 1 of 1Next →